JMP Securities analyst Andrew Boone reiterates Meta Platforms (NASDAQ:META) with a Market Outperform and maintains $240 price target.
A Look Into Gilead Sciences’ Debt
Shares of Gilead Sciences Inc. (NASDAQ:GILD) decreased by 3.87% in the past three months. When understanding a companies…